Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +751.26%
#3 ADO Protocol ADO Protocol +102.63%
#4 Cortex Cortex +94.42%
#5 Ontology Gas Ontology Gas +73.66%
#6 Kinesis Silver Kinesis Silver +54.05%
#7 OpenEden OpenEden +30.51%
#8 Magma Finance Magma Finance +24.84%
#9 QuantixAI QuantixAI +23.16%
#10 EXOD EXOD +22.78%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Flerie AB (publ) Flerie AB (publ)

Flerie AB (publ)

FLERIE
Pozycja w akcjach #18881
Flerie AB (publ) functions as a venture capital entity, concentrating its... Flerie AB (publ) functions as a venture capital entity, concentrating its investments on nascent businesses. The firm actively seeks to fund biotechnology and pharmaceutical companies dedicated to advancing drug discovery and development, or producing innovative tools and applications aimed at addressing pressing global health concerns. Geographically, their investment scope includes Europe, the United States, and Israel. Founded in 2011, Flerie AB (publ) is headquartered in Stockholm, Sweden, and also operates a branch office in London, United Kingdom.
Cena akcji
$2.11
Kapitalizacja rynkowa
$183.02M
Zmiana (1 dzień)
-1.82%
Zmiana (1 rok)
-45.27%
Kraj
SE
Handel Flerie AB (publ) (FLERIE)

Kategoria

Healthcare
Historia stopy dywidendy dla Flerie AB (publ) (FLERIE)
Stopa dywidendy (TTM) dla Flerie AB (publ) (symbol akcji: FLERIE) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Flerie AB (publ) (FLERIE) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
0.57%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
2.01%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
2.74%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
2.69%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
2.47%
US